Clinical Trial Update: TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a tyrosine kinase inhibitor (TKI) with interferon alpha for chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• TKI and Interferon Alpha (TIGER Study regimen)

Snippet

Sponsor: University of Jena | Conditions: Chronic Myeloid Leukemia | Phase 3 | Status: COMPLETED